2Firsts, November 24, 2025— As the global nicotine pouch market experiences rapid expansion, the supply chain has emerged as a decisive variable shaping the future of the industry. PouchEX 2025, one of the world’s earliest trade events dedicated to modern oral products, was held in Stockholm, Sweden, on November 14–15. The event brought together manufacturers, suppliers, technology providers, and brand owners from Europe, Asia, and beyond to discuss supply chain restructuring, regulatory developments, sustainable materials, and next-generation product innovation. As one of the fastest-growing harm-reduction product categories worldwide, nicotine pouches are witnessing surging demand across multiple regions, further amplifying the strategic importance of robust and differentiated supply chain capabilities.
Against this backdrop, Heno Biotech CEO He Ze and Sales Director Li Huang were invited to participate in the conference. On November 15, Li Huang delivered a keynote speech on behalf of Heno Biotech titled “How Supply Chain Upgrading Is Reshaping the Global Nicotine Pouch Industry.” In her presentation, she introduced a structured competency model for nicotine pouch supply chains and shared Heno Biotech’s global strategies and best practices in supply chain upgrading, offering industry decision-makers a comprehensive and supply-chain-centric perspective on future development.
Global Landscape and Structural Challenges: Rapid Growth Driving Supply Chain Transformation
According to Li Huang, the nicotine pouch industry is transitioning from a phase of rapid expansion to one of high-quality growth. Multiple international market forecasts estimate that the global nicotine pouch market will surpass USD 40 billion by 2030, continuing its strong double-digit growth trajectory. While North America and Northern Europe remain mature high-growth markets, emerging demand across Eastern Europe, the Middle East, and the Asia-Pacific region is accelerating a new global distribution of supply chain resources.
However, beneath this rapid growth lie three structural challenges:
1. Rising regulatory thresholds.
Increasingly stringent requirements—ranging from ingredient transparency and toxicological assessment to product consistency—are making supply chain visibility and compliance capabilities essential prerequisites for global market entry.
2. Supply chain mismatches.
Imbalances in materials, manufacturing capacity, processing technologies, and delivery capabilities persist across global markets. In periods of sudden demand spikes, supply chain resilience often becomes the determining factor in a brand’s market performance.
3. Growing focus on industry trust and long-term health concerns.
As consumers and regulators intensify scrutiny of product safety, long-term health impacts, and consistency, the scientific rigor and standardization of supply chains are becoming increasingly critical.
Supply Chain Competency Model for Nicotine Pouches — The Strategic Logic Behind Future Competition
In her presentation, Li Huang introduced Heno Biotech’s “Nicotine Pouch Supply Chain Competency Model,” outlining three foundational capabilities that global manufacturers must develop to stay competitive in the next phase of industry evolution:
1. Scientific and Advanced Processing Capabilities
This includes high-purity nicotine and nicotine salt technologies, scientific validation, and toxicological assessment capabilities. High-standard raw material competence is essential to support safer, more stable, and regulation-aligned product development.
2. Intelligent Manufacturing and Quality Systems
These capabilities encompass scalable production, automated manufacturing lines, GMP-certified facilities, full-process quality monitoring, and consistency control mechanisms. Together, they form the backbone of stable global supply. As environmental expectations rise worldwide, green and sustainable supply chain practices are also becoming increasingly important.
3. Compliance and Global Market Access Capabilities
With regulatory requirements diverging across regions, companies must be equipped with multi-market regulatory understanding, documentation capabilities, and toxicology/risk-assessment support to ensure smooth and compliant entry into global markets.
Li Huang emphasized:
“Future competition will no longer hinge on a single capability, but on an integrated matrix combining science, manufacturing excellence, regulatory competence, and supply chain synergy.”
Heno Biotech’s Supply Chain Solutions — End-to-End Capabilities From Raw Materials to Global Compliance
Building on the core competency model, Li Huang outlined Heno Biotech’s end-to-end supply chain framework designed to support global partners across the entire lifecycle of nicotine pouch production:
High-Purity Natural Nicotine Capabilities
Heno Biotech utilizes plant extraction technologies to produce L-isomer natural nicotine with superior receptor affinity and enhanced metabolic compatibility. These capabilities are reinforced by scientific studies covering metabolic pathways, dopamine-release mechanisms, and related toxicological evaluations.
Scalable and Stable Production Capacity
The company operates a large-scale production facility with an annual output of 600 tons of nicotine. Equipped with advanced purification technologies and a 100,000-class GMP cleanroom, the facility ensures both supply stability and stringent product consistency.
Comprehensive Quality System Aligned With International Standards
A total of 256 quality control checkpoints safeguard every stage from raw material to finished product, covering key indicators such as moisture, purity, microbial content, and impurity levels.
Global Compliance and Market-Access Support
Heno Biotech has completed regulatory submissions to both the U.S. FDA and the EU TPD. The company provides end-market compliance services—including ingredient documentation, toxicological dossiers, and regulatory filing support—to help partners accelerate time-to-market worldwide.
Open-Lab R&D and Custom Product Development
Through its open-laboratory system, Heno Biotech collaborates with brand owners on differentiated formulations, innovative materials, and next-generation product development pipelines.
Li Huang concluded that as the global nicotine pouch industry moves into a phase of high-quality competition, supply chain science, transparency, and sustainability are becoming the most critical shared priorities for the sector.
During discussions with entrepreneurs and industry leaders at the conference, CEO He Ze further noted that supply chain upgrading is not simply a matter of cost or efficiency, but a driver of long-term industry health, regulatory confidence, and global competitiveness. As a leading natural nicotine manufacturer in China, Heno Biotech will continue advancing technological innovation, strengthening supply chain resilience, and enhancing global compliance capabilities—supporting the industry’s transition toward safer, more controlled, and more sustainable development.
“Upgrading the supply chain is the fundamental force behind the long-term, healthy development of the global nicotine pouch industry.”
About Heno Biotech
Founded in 2011 and headquartered in Enshi, Hubei, Heno Biotech has long specialized in the production and multi-functional applications of natural nicotine, becoming a leading player in its niche sector in China. The company adheres to green development and innovation-driven strategies, holding 94 intellectual property achievements and earning honors such as “National Intellectual Property Advantage Enterprise” and “National Specialized and Innovative ‘Little Giant’ Enterprise.”
Heno’s natural nicotine products, with a purity level of 99.9%, are widely used in pharmaceuticals, vaporization, and next-generation tobacco products. As a key supplier of natural nicotine—the core raw material for next-generation tobacco products—Heno Biotech closely monitors the evolving landscape of the NGP sector and remains committed to providing the industry with high-quality, compliant, and health-conscious nicotine solutions.
